Breaking News, Promotions & Moves

Alloy Therapeutics Taps Christian Cobaugh as CEO of Genetic Medicines Division

Cobaugh brings more than 15 years of leadership experience in genetic medicines.

Author Image

By: Charlie Sternberg

Associate Editor

Alloy Therapeutics has appointed Christian Cobaugh, Ph.D., as Chief Executive Officer of Alloy Genetic Medicines, which is dedicated to developing AntiClastic nucleic acid medicines to treat diseases at the genetic level. “Christian is an exceptional addition to Alloy Therapeutics and a natural leader for our Genetic Medicines unit,” said Errik Anderson, CEO and Founder, Alloy Therapeutics. “His experience across mRNA, LNP, and other nucleic acid therapeutics, combined with our AntiClastic pl...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters